UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)
August 30, 2010
 
ALLIED HEALTHCARE PRODUCTS, INC.
 
(Exact name of registrant as specified in its charter)
 
Delaware 
  
0-19266 
  
25-1370721 
(State or Other Jurisdiction
of Incorporation)
  
(Commission
File Number)
  
(IRS Employer
Identification No.)

1720 Sublette Avenue, St. Louis, Missouri 
  
63110
  
 (Address of principal executive offices)
  
 (Zip Code)
  

Registrant’s telephone number, including area code 
(314) 771-2400 
  
Not applicable 
(Former name or former address, if changed since last report) 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 2.02 Results of Operation and Financial Condition.
On August 30, 2010, Allied Healthcare Products, Inc. (the “Company”) issued a press release setting forth results for the fourth quarter and year ended June 30, 2010.  The press release is attached hereto as Exhibit 99.1 and incorporated herein by this reference.  The press release and the information included in this Item 2.02 shall not be deemed “filed” with the Commission.

Item 9.01 Financial Statements and Exhibits.

(a) 
Not applicable.
(b)
Not applicable.
(c)
Not applicable.
(d)
Exhibits.

Exhibit
Number           Description

99                    Press Release dated August 30, 2010

 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

   
ALLIED HEALTHCARE PRODUCTS, INC.
     
 
By:
  
     
Date:  August 30, 2010
  
/s/  Daniel C. Dunn
   
Daniel C. Dunn
   
Chief Financial Officer